학술논문

792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY.
Document Type
Abstract
Source
Journal of Hepatology. Apr2013 Supplement 1, Vol. 58, pS323-S323. 1p.
Subject
Language
ISSN
0168-8278